GlaxoSmithKline plc (GLAXF)

21.10 +0.27 (+1.32%) At close: 02:28PM EDT

GlaxoSmithKline plc

980 Great West Road
Brentford TW8 9GS
United Kingdom
44 20 8047 5000
https://www.gsk.com

Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full-time employees: 90,096

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Emma N. Walmsley	CEO & Director	4.73M	1.02M	1970
Mr. Iain James Mackay	CFO & Exec. Director	3.52M	N/A	1962
Dr. Hal V. Barron F.A.C.C., M.D.	Chief Scientific Officer, Pres of R&D and Director	6.16M	N/A	1963
Ms. Shobie Ramakrishnan	Chief Digital & Technology Officer	N/A	N/A	N/A
Ms. Sarah Elton-Farr	Head of Investor Relations	N/A	N/A	N/A
Mr. James Ford	Sr. VP & Group Gen. Counsel of Legal & Compliance	N/A	N/A	N/A
Ms. Sally Jackson	Sr. VP of Global Communications & CEO Office	N/A	N/A	N/A
Ms. Diana Conrad	Chief People Officer	N/A	N/A	N/A
Mr. David Simon Redfern	Chief Strategy Officer	N/A	N/A	1966
Mr. Philip C. Thomson	Pres of Global Affairs	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Corporate governance

GlaxoSmithKline plc’s ISS governance QualityScore as of 1 May 2022 is 9. The pillar scores are Audit: 10; Board: 3; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.